A detailed history of Intech Investment Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 387,330 shares of DXCM stock, worth $31.1 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
387,330
Previous 17,743 2083.0%
Holding current value
$31.1 Million
Previous $2.01 Million 1190.8%
% of portfolio
0.3%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$64.0 - $116.06 $23.7 Million - $42.9 Million
369,587 Added 2083.0%
387,330 $26 Million
Q2 2024

Aug 12, 2024

SELL
$110.31 - $140.45 $90,674 - $115,449
-822 Reduced 4.43%
17,743 $2.01 Million
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $2.12 Million - $2.6 Million
18,565 New
18,565 $2.57 Million
Q2 2023

Oct 18, 2024

SELL
$112.47 - $130.98 $527,596 - $614,427
-4,691 Reduced 44.67%
5,811 $746,000
Q2 2023

Aug 09, 2023

SELL
$112.47 - $130.98 $527,596 - $614,427
-4,691 Reduced 44.67%
5,811 $746,000
Q1 2023

Oct 18, 2024

SELL
$104.0 - $122.92 $753,064 - $890,063
-7,241 Reduced 40.81%
10,502 $1.22 Million
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $60,528 - $71,539
-582 Reduced 5.25%
10,502 $1.22 Million
Q4 2022

Oct 18, 2024

SELL
$84.98 - $122.67 $257,319 - $371,444
-3,028 Reduced 21.46%
11,084 $1.26 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $257,319 - $371,444
-3,028 Reduced 21.46%
11,084 $1.26 Million
Q3 2022

Oct 18, 2024

SELL
$76.35 - $94.18 $277,226 - $341,967
-3,631 Reduced 20.46%
14,112 $1.14 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $3.38 Million - $4.17 Million
-44,237 Reduced 75.81%
14,112 $1.14 Million
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $3.97 Million - $7.75 Million
58,349 New
58,349 $4.35 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.